Impact of age, comorbidity, and polypharmacy on receipt of systemic therapy in advanced cancers: A retrospective population-based study

Rebekah Rittberg & David E. Dawe et al. · 2024-01-13

8Citations
TL;DR

Increased age, polypharmacy, and comorbidity were each independently associated with decreased receipt of ST in people with advanced cancers.

AI-generated by Semantic Scholar

Authors
Rebekah Rittberg, Kathleen Decker, Pascal Lambert, Jen Bravo, Philip St. John, Donna Turner, Piotr Czaykowski, David E. Dawe